デフォルト表紙
市場調査レポート
商品コード
1555495

連続バイオプロセス市場:製品別、運営規模別、プロセス別、用途別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測

Continuous Bioprocessing Market, By Product, By Scale of Operation, By Process, By Application, By End-user, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 380 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
連続バイオプロセス市場:製品別、運営規模別、プロセス別、用途別、エンドユーザー別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測
出版日: 2024年08月20日
発行: AnalystView Market Insights
ページ情報: 英文 380 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

連続バイオプロセス市場規模は2023年に2億1,460万米ドルとなり、2024年から2032年にかけてCAGR21.40%で拡大

連続バイオプロセス市場 - 市場力学

バイオ医薬品需要の増加が市場成長を促進

バイオ医薬品は、その高い活性と選択性、副作用の少なさ、特定の分子を標的とする能力から、需要が高まっています。がん、炎症性腸疾患(IBD)、関節リウマチ(RA)などの免疫介在性炎症性疾患(IMID)の治療は、バイオ医薬品にますます依存するようになっています。この着実な増加は、バイオ医薬品承認市場の拡大も後押ししています。米国FDAの報告によると、2022年に承認される医薬品のうち15品目が生物製剤で、2020年の13品目とは対照的でした。さらに、商業生産における連続製造技術の導入は製造コストを下げます。生産性が向上するため、バイオ医薬品のコストが下がり、医薬品へのアクセスが容易になり、標準治療が向上します。バイオ医薬品製造は、連続バイオプロセスによって変化しています。連続バイオプロセスは、従来のフロー製造と比較して優れているため、バイオ医薬品の製造に広く使用されるようになってきています。これらの利点には、プロセス設計の柔軟性の向上、プロセス経済性の改善、スケールアップの容易さ、開発期間の短縮などが含まれます。

連続バイオプロセス市場 - 主要な洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間(2024年~2032年)に約21.40%のCAGRで毎年成長すると推定されます。

製品セグメンテーションに基づくと、濾過システムとデバイスカテゴリは、2023年に最大の市場シェアを示すと予測されました。

運営規模に基づくと、2023年には商業運営カテゴリーが主要セグメントとなりました。

用途別では、モノクローナル抗体カテゴリーが2023年の主要セグメントでした。

エンドユーザー別では、製薬・バイオテクノロジー企業が2023年の主要セグメントでした。

地域別では、北米が2023年の主要収益源でした。

連続バイオプロセス市場 - セグメンテーション分析:

世界の連続バイオプロセス市場は、製品、運営規模、プロセス、用途、エンドユーザー、地域によって区分されます。

市場は運営規模に基づいて2つのカテゴリーに分けられます:商業運営と臨床運営です。商業運営カテゴリーが市場を独占しています。ワクチン、細胞・遺伝子治療薬、モノクローナル抗体、その他の生物製剤など、バイオ医薬品に対する旺盛な需要が商業部門を支えています。さらに、世界人口の高齢化と慢性疾患の流行に伴い、高度なバイオ医薬品へのニーズが拡大しており、これが商業部門の拡大をさらに後押ししています。さらに、従来のバッチ処理技術と比較して、連続バイオプロセスは生産性の向上やプロセス制御の改善といった利点を提供するため、大規模な商業生産に適しています。

市場はプロセスによって2つのカテゴリーに分けられます:下流バイオプロセスと上流バイオプロセスです。下流バイオプロセスのカテゴリーが市場を独占しており、予測期間中もその優位性を維持するとみられます。同分野の台頭は、規制基準を満たし、製品の品質を達成し、バイオ医薬品の価値を大幅に高める上で重要な機能を担っていることに起因しています。さらに、製造業者は、アウトソーシング傾向の高まりと生物製剤の需要に鑑み、製品の品質と安全性を確保するため、堅牢で効率的な精製プロセスを優先しており、その結果、同分野の成長が促進されています。さらに、バイオ製薬企業は、プロセスの生産性、効率性、拡張性を向上させることにより、下流処理ソリューションの技術革新を進め、この分野の市場成長をさらに促進することができます。

連続バイオプロセス市場 - 地理的洞察

地域的には、この市場は北米、中南米、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

予測期間を通じて、北米は連続バイオプロセスの世界市場で最大のシェアを占めると予想されています。有名な製薬会社を含む数多くのバイオ医薬品企業が北米に拠点を置いています。これらの企業は、生物学的製剤の創製と販売におけるパイオニアであり、生産プロセスの最適化、生産量の向上、製品品質の保証を目的とした継続的バイオプロセス技術の必要性を煽っています。さらにこの地域は、バイオ加工技術の進歩を支える学術機関、研究施設、バイオテクノロジーハブの強力なネットワークを誇っています。

さらに、連続バイオプロセス市場は、バイオ医薬品セクターの成長、ライフサイエンス研究の増加、バイオテクノロジー・製薬企業による投資の増加、(CMO)市場の拡大などの要因によって、アジア太平洋の予測期間中に世界で最も速い速度で拡大すると予想されています。アジア太平洋の企業や研究機関は、最先端のバイオプロセスプラットフォームを構築するために多額の研究開発投資を行い、継続的なバイオプロセスの改善を推進し、世界市場での競争力を維持するのに役立っています。

連続バイオプロセス市場 - 競争環境:

ダイナミックで変化に富んだ連続バイオプロセス分野には、Merck KGaA、Sartorius AG、Thermo Fisher Scientificなど、さまざまなタイプのプレーヤーが存在します。技術の発展とバイオ医薬品へのニーズの高まりがさらなる技術革新と市場統合に拍車をかけ、市場の競争は激化すると予測されます。

目次

第1章 連続バイオプロセス市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 連続バイオプロセスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 連続バイオプロセス産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 連続バイオプロセス市場:COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 連続バイオプロセス市場情勢

  • 連続バイオプロセス市場シェア分析、2023年
  • 内訳データ:主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 連続バイオプロセス市場:製品別

  • 概要
    • セグメントシェア分析:製品別
    • クロマトグラフィーシステム・消耗品
    • 濾過システム・装置
    • バイオリアクター
    • 細胞培養培地、細胞株、緩衝液、試薬
    • その他の製品

第8章 連続バイオプロセス市場:運営規模別

  • 概要
    • セグメントシェア分析:運営規模別
    • 商業運営
    • 臨床業務

第9章 連続バイオプロセス市場:プロセス別

  • 概要
    • セグメントシェア分析:プロセス別
    • 下流バイオプロセス
    • 上流バイオプロセス

第10章 連続バイオプロセス市場:用途別

  • 概要
    • セグメントシェア分析:用途別
    • モノクローナル抗体
    • ワクチン
    • 細胞・遺伝子治療
    • その他のア用途

第11章 連続バイオプロセス市場:エンドユーザー別

  • 概要
    • セグメントシェア分析:エンドユーザー別
    • 製薬・バイオテクノロジー企業
    • 契約調査機関・契約製造機関
    • 学術・研究機関

第12章 連続バイオプロセス市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第13章 主要ベンダー分析 - 連続バイオプロセス産業

  • 競合ダッシュボード
  • 企業プロファイル
    • 3M Company
    • Bionet
    • FUJIFILM HOLDINGS CORPORATION
    • Merck KGaA
    • Repligen Corporation
    • Danaher Corporation(Pall Corporation)
    • Eppendorf SE
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Wuxi Biologics
    • その他

第14章 アナリストの全方位展望

目次
Product Code: ANV3604

REPORT HIGHLIGHT

Continuous Bioprocessing Market size was valued at USD 214.6 Million in 2023, expanding at a CAGR of 21.40% from 2024 to 2032.

The integrated continuous unit processes used in continuous bioprocessing do not have intermediary holding tanks; instead, the product flows continuously through them and into containers. Extremely intense processing with brief downtimes is a characteristic of continuous unit operations. A multi-column chromatography system, a perfusion bioreactor, and multi-column intermediate purification are components of an end-to-end bioprocess. For continuous biopharmaceutical manufacturing, some pharmaceutical and biopharmaceutical producers use a hybrid strategy where just the upstream or downstream process is continuous.

Continuous Bioprocessing Market- Market Dynamics

Increased Demand for Biopharmaceuticals to Propel Market Growth

Biopharmaceuticals are in greater demand because of their high activity and selectivity, low side effects, and capacity to target particular molecules. The treatment of immune-mediated inflammatory diseases (IMIDs), such as cancer, inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), is becoming more and more dependent on biopharmaceuticals. The steady rise also aids the market's expansion in biopharmaceutical approvals. The U.S. FDA reports that of all the medications authorized in 2022, 15 were biologics, as opposed to 13 in 2020. Additionally, implementing continuous manufacturing techniques in commercial production lowers manufacturing costs. It increases productivity, which lowers the cost of biopharmaceutical products, increases accessibility to medications, and enhances the standard of care. Biopharmaceutical manufacturing is changing as a result of continuous bioprocessing. Continuous bioprocessing is becoming more widely used in the production of biopharmaceuticals due to its advantages over traditional flow manufacturing. These advantages include enhanced process design flexibility, improved process economics, ease of scale-up, and quick development timelines.

Continuous Bioprocessing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.40% over the forecast period (2024-2032)

Based on product segmentation, the Filtration Systems and Devices category was predicted to show maximum market share in the year 2023

Based on the scale of operation segmentation, the commercial operations category was the leading segment in 2023

Based on application segmentation, the Monoclonal Antibodies category was the leading segment in 2023

Based on end-user segmentation, the Pharmaceutical and Biotechnology Companies category was the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Bioprocessing Market- Segmentation Analysis:

The Global Continuous Bioprocessing Market is segmented based on Product, Scale of Operation, Process, Application, End-user and Region.

The market is divided into two categories based on scale of operation: Commercial Operations and Clinical Operations. The commercial operations category dominates the market. The strong demand for biopharmaceutical goods, such as vaccines, cell and gene therapies, monoclonal antibodies, and other biologics, helps the commercial sector. Additionally, the need for sophisticated biopharmaceutical medicines is expanding as the world's population ages and the prevalence of chronic diseases rises, which is propelling the commercial segment's expansion even further. Furthermore, compared to conventional batch processing techniques, continuous bioprocessing provides benefits like increased productivity and improved process control, which makes it a good fit for large-scale commercial production.

The market is divided into two categories based on Process: Downstream Bioprocess and Upstream Bioprocess. The downstream bioprocess category dominates the market and is likely to maintain its dominance during the forecast period. The segment's rise is ascribed to its vital function in fulfilling regulatory standards, achieving product quality, and significantly enhancing the value of biopharmaceutical goods. Additionally, manufacturers prioritize robust and efficient purification processes to ensure product quality and safety in light of growing outsourcing trends and the demand for biologics, which in turn enhances segmental growth. Moreover, ongoing innovations in downstream processing solutions allow biopharmaceutical companies to further drive market growth in this segment by improving process productivity, efficiency, and scalability.

Continuous Bioprocessing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Throughout the forecast period, North America is anticipated to hold the greatest share of the global market for Continuous Bioprocessing. Numerous biopharmaceutical businesses, including well-known pharmaceutical corporations, are based in North America. These businesses are pioneers in the creation and marketing of biologic medications, which fuels the need for ongoing bioprocessing technology to optimize production processes, boost output, and guarantee product quality. Furthermore, this area is proud of its strong network of academic institutions, research facilities, and biotechnology hubs that support the advancement of bioprocessing technology.

In addition, the Continuous Bioprocessing market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific driven by factors like the growth of the biopharmaceutical sector, a rise in life sciences research, an increase in investments made by biotechnology and pharmaceutical businesses, and the expanding market for (CMOs). Companies and research institutions in Asia Pacific make significant R&D investments to create state-of-the-art bioprocessing platforms that propel continual bioprocessing improvements and help them keep a competitive edge in the worldwide market.

Continuous Bioprocessing Market- Competitive Landscape:

There are many different types of players in the dynamic and varied continuous bioprocessing sector, including Merck KGaA, Sartorius AG, and Thermo Fisher Scientific. The market is predicted to become more competitive as technology develops and the need for biopharmaceuticals rises, spurring additional innovation and market consolidation.

Recent Developments:

August 2023: To improve upstream process intensification, Sartorius and Repligen Corporation unveiled an integrated bioreactor system that combined Biostat STR and XCell ATF technology. It is anticipated that the launch will assist the business in growing both its sales revenue and product portfolio.

March 2023: Curia and Corning worked together to establish and expedite continuous-flow manufacturing and development programs for the global chemical and biopharmaceutical sectors. Through this partnership, Corning's G1 production system-which supports the use of flow-chemistry technology to produce APIs of higher quality-will be installed for the first time in the world.

July 2022: Cytiva opened a new location in Muskegon, Michigan, to expand its business. The new manufacturing facility for chromatography resins is a component of Cytiva's investment in growth.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS BIOPROCESSING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Company
  • Bionet
  • FUJIFILM HOLDINGS CORPORATION
  • Merck KGaA
  • Repligen Corporation
  • Danaher Corporation (Pall Corporation)
  • Eppendorf SE
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Wuxi Biologics
  • Others

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Chromatography Systems and Consumables
  • Filtration Systems and Devices
  • Bioreactors
  • Cell Culture Media, Cell Lines, Buffers and Reagents
  • Other Products

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY SCALE OF OPERATION- MARKET ANALYSIS, 2019 - 2032

  • Commercial Operations
  • Clinical Operations

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY PROCESS- MARKET ANALYSIS, 2019 - 2032

  • Downstream Bioprocess
  • Upstream Bioprocess

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Other Applications

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations and Contract Manufacturing Organizations
  • Academic and Research Institutes

GLOBAL CONTINUOUS BIOPROCESSING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Continuous Bioprocessing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Continuous Bioprocessing Market Snippet by Product
    • 2.1.2. Continuous Bioprocessing Market Snippet by Scale of Operation
    • 2.1.3. Continuous Bioprocessing Market Snippet by Process
    • 2.1.4. Continuous Bioprocessing Market Snippet by Application
    • 2.1.5. Continuous Bioprocessing Market Snippet by End-user
    • 2.1.6. Continuous Bioprocessing Market Snippet by Country
    • 2.1.7. Continuous Bioprocessing Market Snippet by Region
  • 2.2. Competitive Insights

3. Continuous Bioprocessing Key Market Trends

  • 3.1. Continuous Bioprocessing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Continuous Bioprocessing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Continuous Bioprocessing Market Opportunities
  • 3.4. Continuous Bioprocessing Market Future Trends

4. Continuous Bioprocessing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Continuous Bioprocessing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Continuous Bioprocessing Market Landscape

  • 6.1. Continuous Bioprocessing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Continuous Bioprocessing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Chromatography Systems and Consumables
    • 7.1.3. Filtration Systems and Devices
    • 7.1.4. Bioreactors
    • 7.1.5. Cell Culture Media, Cell Lines, Buffers and Reagents
    • 7.1.6. Other Products

8. Continuous Bioprocessing Market - By Scale of Operation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Scale of Operation, 2023 & 2032 (%)
    • 8.1.2. Commercial Operations
    • 8.1.3. Clinical Operations

9. Continuous Bioprocessing Market - By Process

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Process, 2023 & 2032 (%)
    • 9.1.2. Downstream Bioprocess
    • 9.1.3. Upstream Bioprocess

10. Continuous Bioprocessing Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2. Monoclonal Antibodies
    • 10.1.3. Vaccines
    • 10.1.4. Cell and Gene Therapy
    • 10.1.5. Other Applications

11. Continuous Bioprocessing Market - By End-user

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 11.1.2. Pharmaceutical and Biotechnology Companies
    • 11.1.3. Contract Research Organizations and Contract Manufacturing Organizations
    • 11.1.4. Academic and Research Institutes

12. Continuous Bioprocessing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Continuous Bioprocessing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Continuous Bioprocessing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Continuous Bioprocessing Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Continuous Bioprocessing Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Continuous Bioprocessing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Process, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Continuous Bioprocessing Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. 3M Company
    • 13.2.2. Bionet
    • 13.2.3. FUJIFILM HOLDINGS CORPORATION
    • 13.2.4. Merck KGaA
    • 13.2.5. Repligen Corporation
    • 13.2.6. Danaher Corporation (Pall Corporation)
    • 13.2.7. Eppendorf SE
    • 13.2.8. Sartorius AG
    • 13.2.9. Thermo Fisher Scientific Inc.
    • 13.2.10. Wuxi Biologics
    • 13.2.11. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us